Table 1 Patient characteristics by the vascular access type
Total (N = 529) | RC AVF (N = 264) | BC AVF (N = 168) | AVG (N = 97) | P | |
|---|---|---|---|---|---|
Age (years) | 73.6 ± 6.0 | 72.9 ± 5.8 | 74.2 ± 6.0 | 74.9 ± 6.4 | 0.007 |
Men (N, %) | 324 (61.2) | 176 (66.7) | 92 (54.8) | 56 (57.7) | 0.087 |
BMI (kg/m2) | 23.1 ± 3.3 | 23.5 ± 3.1 | 22.8 ± 3.5 | 22.7 ± 3.3 | 0.043 |
SBP (mmHg) | 130.0 ± 19.5 | 131.0 ± 18.6 | 128.7 ± 18.1 | 129.2 ± 24.0 | 0.473 |
DBP (mmHg) | 69.3 ± 10.8 | 69.7 ± 10.7 | 68.4 ± 10.3 | 70.0 ± 12.1 | 0.466 |
Hemoglobin (g/dL) | 10.2 ± 1.4 | 10.1 ± 1.4 | 10.0 ± 1.4 | 10.5 ± 1.4 | 0.039 |
Albumin (g/dL) | 3.5 ± 0.5 | 3.5 ± 0.5 | 3.5 ± 0.6 | 3.4 ± 0.4 | 0.126 |
Total chol. (g/dL) | 153.4 ± 39.2 | 151.7 ± 37.5 | 153.7 ± 38.8 | 158.1 ± 44.8 | 0.428 |
Calcium (mg/dL) | 8.5 ± 0.7 | 8.5 ± 0.7 | 8.4 ± 0.7 | 8.6 ± 0.7 | 0.222 |
Phosphorus (mg/dL) | 4.2 ± 1.1 | 4.2 ± 1.1 | 4.1 ± 1.0 | 4.1 ± 1.2 | 0.614 |
Glucose (mg/dL) | 123.7 ± 56.6 | 126.1 ± 57.4 | 117.2 ± 51.0 | 128.7 ± 62.8 | 0.206 |
PTH (pg/mL) | 168.5 ± 149.1 | 170.8 ± 149.5 | 173.4 ± 142.6 | 147.0 ± 169.6 | 0.670 |
Uric Acid (mg/dL) | 6.7 ± 2.1 | 6.8 ± 2.1 | 6.6 ± 2.4 | 6.2 ± 1.7 | 0.031 |
hs-CRP (mg/dL) | 2.4 ± 4.3 | 2.1 ± 3.8 | 2.4 ± 4.8 | 3.1 ± 4.6 | 0.254 |
Follow up duration (month) | 67.1 ± 44.6 | 71.0 ± 46.5 | 66.0 ± 41.3 | 58.1 ± 43.8 | 0.048 |
Etiology of ESRD | 0.538 | ||||
DM (N, %) | 247 (45.7) | 126 (47.7) | 74 (44.0) | 42 (43.3) | |
HTN (N, %) | 40 (7.6) | 20 (7.6) | 13 (7.7) | 7 (7.2) | |
GN (N, %) | 35 (6.6) | 18 (6.8) | 8 (4.8) | 9 (9.3) | |
Others (N, %) | 61 (11.3) | 22 (8.3) | 24 (14.3) | 14 (14.4) | |
Unknown (N, %) | 152 (28.7) | 78 (29.5) | 49 (29.2) | 25 (25.6) | |
Comorbidities | |||||
DM (N, %) | 304 (57.5) | 157 (59.5) | 93 (55.4) | 54 (55.7) | 0.648 |
HTN (N, %) | 419 (79.2) | 218 (82.6) | 131 (78.0) | 70 (72.2) | 0.087 |
CAD (N, %) | 120 (22.7) | 60 (22.7) | 32 (19.0) | 28 (28.9) | 0.184 |
PVD (N, %) | 26 (4.9) | 9 (3.4) | 11 (6.5) | 6 (6.2) | 0.276 |
CVD (N, %) | 106 (20.0) | 53 (20.1) | 27 (16.1) | 26 (26.8) | 0.110 |
CHF (N, %) | 77 (14.6) | 32 (12.1) | 31 (18.5) | 14 (14.4) | 0.191 |
Malignancy (N, %) | 98 (18.3) | 75 (17.2) | 23 (23.2) | 98 (18.3) | 0.161 |